Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.690
-0.070 (-2.54%)
Jan 29, 2026, 1:45 PM EST - Market open
Genelux Market Cap
Genelux has a market cap or net worth of $119.13 million as of January 29, 2026. Its market cap has increased by 43.15% in one year.
Market Cap
119.13M
Enterprise Value
99.84M
1-Year Change
43.15%
Ranking
Category
Stock Price
$2.69
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $119.13M, a decrease of -15.93%. That is a compound annual growth rate of -5.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 122.23M | -25.48% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oramed Pharmaceuticals | 138.51M |
| Cardiff Oncology | 134.72M |
| Spero Therapeutics | 133.52M |
| Adlai Nortye | 132.84M |
| Whitehawk Therapeutics | 131.02M |
| Codexis | 129.16M |
| Karyopharm Therapeutics | 129.09M |
| Alpha Cognition | 128.17M |